Sleep Number (SNBR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
25 Dec, 2025Executive summary
Leadership transition announced: Linda Findley appointed as new President and CEO, effective April 7, 2025, succeeding Shelly Ibach, who is retiring after 18 years; Phillip M. Eyler to become independent Chair.
The company executed a significant operating model transformation in 2024, focusing on cost reduction, margin improvement, and financial resilience amid a weak mattress industry environment.
Fourth quarter net sales declined 12% year-over-year to $377 million; full-year net sales down 11% to $1.68 billion.
Despite a challenging demand environment, the company delivered a 43% year-over-year increase in Q4 adjusted EBITDA and met the midpoint of full-year EBITDA guidance.
Q4 net loss narrowed to $5 million from $25 million last year; full-year net loss was $20 million versus $15 million prior year.
Financial highlights
Q4 net sales declined 12% year-over-year to $377 million, with a 5% reduction in store count contributing 1-2 points of pressure.
Full-year 2024 net sales were $1.68 billion, down 11% from the prior year, with demand down high single digits.
Q4 gross margin reached 59.9%, up 330 basis points year-over-year; full-year gross margin was 59.6%, a 190 basis point increase over 2023.
Q4 adjusted EBITDA was $26 million, up 43% year-over-year; full-year adjusted EBITDA was $120 million, at the midpoint of guidance.
Net cash from operating activities was $27 million for the year, up $36 million year-over-year; free cash flow was $4 million, up $70 million.
Outlook and guidance
No financial outlook for 2025 provided due to the CEO transition; guidance will be issued later after the new CEO evaluates strategies and trends.
Industry demand expected to remain pressured in the first half of 2025, with potential for improvement in the back half, though recent trends suggest a more conservative outlook.
The company is prepared to continue cost reductions and operational efficiency initiatives if demand remains soft.
Latest events from Sleep Number
- Proxy seeks board declassification, equity plan expansion, and governance modernization.SNBR
Proxy filing24 Mar 2026 - Turnaround strategy and cost reductions set the stage for growth and free cash flow in 2026.SNBR
Investor presentation12 Mar 2026 - Cost savings and new products drive turnaround, setting up double-digit EBITDA growth for 2026.SNBR
Q4 202512 Mar 2026 - Gross margin and cost improvements offset sales declines, supporting full-year EBITDA guidance.SNBR
Q2 20242 Feb 2026 - Gross margin hit a three-year high as cost cuts offset a 10% sales decline in Q3.SNBR
Q3 202417 Jan 2026 - Major transformation underway with cost cuts, new products, and a focus on value-driven growth.SNBR
28th Annual ICR Conference 202613 Jan 2026 - Transformation plan targets growth, efficiency, and strong free cash flow in 2026.SNBR
Investor presentation13 Jan 2026 - Q1 2025 sales dropped 16% with a $8.6–$9M net loss, but gross margin rose to 61.2%.SNBR
Q1 202523 Dec 2025 - Board proposes governance reforms, new CEO, and equity plan changes amid industry headwinds.SNBR
Proxy Filing1 Dec 2025